#Careinovation

A bold wave of new research on psilocybin, the psychedelic compound found in certain mushrooms, is reshaping possibilities for treating depression. Across major trials, researchers report rapid mood improvements following guided, therapist-supported administration, with improvements sometimes lasting weeks to months. As the world digests these findings, Thai health officials, clinicians, and families are asking what this could mean for Thailand’s mental health crisis—where access to care remains uneven, stigma persists, and conventional medications don’t work for everyone. The answers are complex, but the potential implications for Thai patients, carers, and the wider health system are increasingly concrete.